Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Stefan Zajic"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/061a73a2c64444258cffc2f8cd9d47f0
Autor:
Stefan Zajic, Oleg Demin, Galina Kolesova, Natalia Ramos-Hernandez, Thomas Faitg, Lourdes Cucurull-Sanchez
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/728371f93f284b559aba0bb4ea7a0599
Autor:
Alexandra Gyurdieva, Stefan Zajic, Ya-Fang Chang, E. Andres Houseman, Shan Zhong, Jaegil Kim, Michael Nathenson, Thomas Faitg, Mary Woessner, David C. Turner, Aisha N. Hasan, John Glod, Rosandra N. Kaplan, Sandra P. D’Angelo, Dejka M. Araujo, Warren A. Chow, Mihaela Druta, George D. Demetri, Brian A. Van Tine, Stephan A. Grupp, Gregg D. Fine, Ioanna Eleftheriadou
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-18 (2022)
Biomarkers predictive of response to T cell therapy remain to be better defined. This study identifies potential predictive and pharmacodynamic markers of response to NY-ESO-1 T-cell therapy in a solid tumor that may inform lymphodepletion, cell dose
Externí odkaz:
https://doaj.org/article/96c810f6a32a4df78125147d2a952087
Autor:
Dara M. Kusic, Jessica Heil, Stefan Zajic, Andrew Brangan, Oluseun Dairo, Stacey Heil, Gerald Feigin, Sherri Kacinko, Russell J. Buono, Thomas N. Ferraro, Rachel Rafeq, Rachel Haroz, Kaitlan Baston, Elliot Bodofsky, Michael Sabia, Matthew Salzman, Alissa Resch, Jozef Madzo, Laura B. Scheinfeldt, Jean-Pierre J. Issa, Jaroslav Jelinek
Publikováno v:
PLoS ONE, Vol 18, Iss 11 (2023)
Externí odkaz:
https://doaj.org/article/af23a40b324b484bbe9591accc2c7471
Autor:
Jessica Heil, Stefan Zajic, Emily Albertson, Andrew Brangan, Iris Jones, Wendy Roberts, Michael Sabia, Elliot Bodofsky, Alissa Resch, Rachel Rafeq, Rachel Haroz, Russell Buono, Thomas N. Ferraro, Laura Scheinfeldt, Matthew Salzman, Kaitlan Baston
Publikováno v:
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-8 (2021)
Abstract Background The opioid use disorder and overdose crisis in the United States affects public health as well as social and economic welfare. While several genetic and non-genetic risk factors for opioid use disorder have been identified, many o
Externí odkaz:
https://doaj.org/article/db428ce001fe416395fc501d53871073
Autor:
Dara Kusic, Jessica Heil, Stefan Zajic, Andrew Brangan, Oluseun Dairo, Gretchen Smith, Diego Morales-Scheihing, Russell J. Buono, Thomas N. Ferraro, Rachel Haroz, Matthew Salzman, Kaitlan Baston, Elliot Bodofsky, Michael Sabia, Alissa Resch, Laura B. Scheinfeldt
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1863 (2022)
Pharmacogenetics (PGx) has the potential to improve opioid medication management. Here, we present patient perception data, pharmacogenetic data and medication management trends in patients with chronic pain (arm 1) and opioid use disorder (arm 2) tr
Externí odkaz:
https://doaj.org/article/55bda08e9fb541fda32d7505a8423fcb
Autor:
David Turner, John Glod, Alexandra Gyurdieva, Stefan Zajic, Ya-Fang Chang, E Andres Houseman, Shan Zhong, Jaegil Kim, Laura Johnson, Jenna Tress, Aisha Hasan, Victoria Chiou, Naimish Pandya, Dejka Araujo, Warren Chow, Mihaela Druta, George Demetri, Brian Van Tine
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/f169156f7e384e7ea3190d60112f28c7
Autor:
D. Hamish Wright, PhD, Ramon Mols, BSc, Kevin R Brown, BA, Geng-Chang Yeh, MD, PhD, Eric Woolf, PhD, Lisa Hickey, MS, Stefan Zajic, PhD
Publikováno v:
Current Therapeutic Research, Vol 77, Iss C, Pp 116-121 (2015)
Objective: This study was designed to demonstrate that alendronate (ALN)/vitamin D3 combination tablets (ALN/D5600) are bioequivalent to corresponding doses of ALN and vitamin D3 as individual tablets in healthy Taiwanese volunteers. Methods: In this
Externí odkaz:
https://doaj.org/article/2b1f5d060e5e4ec6b8236b0da5b9aa99
Autor:
Taiga Nishihori, James E. Hoffman, Anne Huff, Gurpreet S. Kapoor, Ioanna Eleftheriadou, Stefan Zajic, Alisa Urbano, Sunil Suchindran, Michael Chisamore, Jimson W. D’Souza, Thomas Faitg, Aaron P. Rapoport
Publikováno v:
Blood Advances. 7:1168-1177
This pilot study assessed the safety and efficacy of letetresgene autoleucel (lete-cel; GSK3377794), a genetically modified autologous T-cell therapy targeting New York esophageal squamous cell carcinoma-1 (NY-ESO-1)/L antigen family member 1 isoform
Autor:
Gurpreet Kapoor, Stefan Zajic, Sunil Suchindran, Jaegil Kim, Uma Saxena, Aishwarya Bhaskar, Heather Kaczynski, Michael Nathenson, Jimson D'Souza, Benjamin Rich, Sandra D'Angelo, Mihaela Druta, Brian Van Tine, Neeta Somaiah, David Liebner, Scott Schuetze, Ioanna Eleftheriadou
Publikováno v:
Regular and Young Investigator Award Abstracts.